Popular Cholesterol Drug Activates the Same Receptors as Medical Marijuana
New research in The FASEB Journal suggests that fenofibrate activates cannabinoid receptors and may become a viable treatment option for relieving pain, stimulating appetite,...
Study Shows Patients Taking Lipitor Show Significant Cardiovascular Benefit
Preliminary results showed diabetic patients who took the cholesterol-lowering medicine Lipitor had significantly fewer heart attacks, strokes and surgical procedures compared to patients who received placebo.
Healthy Weight Means Healthier Blood Lipid Profile In Children
Study shows maintaining a healthy weight in children may be one good way for them to keep a healthy blood lipid profile and grow up with a happy heart.
Diabetes Medication May Help Slow Plaque Build-up in Coronary Arteries
A comparison of two types of medications to treat type 2 diabetes finds that pioglitazone is more effective at lowering the rate of progression of plaque build-up in the coronary arteries than glimepiride, according to a study in the April 2 issue of JAMA.
Researchers Report Breakthrough in Lowering Cholesterol, Fatty Acids
Researchers have found a way to reduce the amount of bad cholesterol and fatty acids that end up in the blood from food the body metabolizes, a key discovery that could lead to new drugs to treat and reverse the effects of Type 2 diabetes and heart disease related to obesity.
False Sense of Security Among Statin Users Leading to Heart Disease and Illnesses
People who take statin drugs to lower their cholesterol appear to have developed a false sense of security that could lead to heart disease and other obesity-related illnesses.
Study: Statin Potency Linked to Muscle Side Effects
A study reports that muscle problems reported by patients taking statins were related to the strength or potency of the given cholesterol-lowering drugs.
Key Fat and Cholesterol Cell Regulator Identified, Promising Target
Researchers have identified how a molecular switch regulates fat and cholesterol production, a step that may help advance treatments for metabolic syndrome, the constellation of diseases that includes high cholesterol, obesity, type II diabetes, and high blood pressure.
New Review Suggests Caution on Drugs to Raise
A new review suggests that so far, only modest evidence supports the use of most medications to raise levels of high-density lipoprotein (good cholesterol).
High Hostility May Predict Heart Disease More Than Other Risk Factors Such As Cholesterol
Hostility may predict heart disease more often than traditional coronary heart disease risk factors like high cholesterol, cigarette smoking and weight.
Belly Fat May Affect Liver Function
A study suggests the release of lipids from abdominal fat, which drains directly to the liver, increases overnight, providing additional insight as to how abdominal fat is associated with type 2 diabetes risk.
Diet As Good as Drug for Lowering Cholesterol, Says Study
Researchers shown that a vegetarian diet composed of specific plant foods can lower cholesterol as effectively as a drug treatment.
Study Reinforces Link Between Obesity, High-Fat Meals and Heart Disease
The effect of a high-fat meal on blood vessel walls can vary among individuals depending on factors such as their waist size and triglyceride levels.
Gap Widens Between Optimal Versus Actual Cholesterol Levels
An estimated 63 million adults have low-density lipoprotein cholesterol (LDL-C) levels higher than what would be ideal as recommended.
Widely Used Cholesterol Medicine May Increase Muscle Pain
Up to 75-percent of patients who take a widely used cholesterol medicine to treat high cholesterol may end up suffering from muscle pain.
Volanesorsen Improves Blood Sugar Control in Type 2 Diabetes
Penn researcher finds volanesorsen improves insulin sensitivity, glucose control for type 2 diabetics with high triglycerides. High triglycerides -- a type of fat, or lipid,...
